ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TBIO Telesis Bio Inc

0.3135
-0.0407 (-11.49%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Telesis Bio Inc TBIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0407 -11.49% 0.3135 14:00:02
Open Price Low Price High Price Close Price Previous Close
0.3396 0.3162 0.3591 0.33 0.3542
more quote information »

Recent News

Date Time Source Heading
18/4/202423:00GLOBETelesis Bio Inc. announces strategic focus on game-changing..
29/3/202407:05GLOBETelesis Bio Reports Fourth Quarter and Full Year 2023..
06/3/202410:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202410:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202409:00EDGAR2Form 8-K - Current report
27/2/202401:15GLOBETelesis Bio Announces Select Preliminary Fourth Quarter..
01/12/202309:00EDGAR2Form 8-K - Current report
14/11/202308:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:32EDGAR2Form 8-K - Current report
14/11/202308:22GLOBETelesis Bio Reports Third Quarter 2023 Financial Results
10/11/202309:00EDGAR2Form 8-K - Current report
08/11/202301:00GLOBETelesis Bio to Report Third Quarter Financial Results on..
04/11/202303:00GLOBETelesis Bio Announces Commercial Release of Cell-free..
25/10/202307:30EDGAR2Form 8-K - Current report
29/9/202305:48GLOBETelesis Bio Announces Commercial Release of BioXp® NGS..
23/9/202307:00EDGAR2Form 8-K - Current report
30/8/202306:05GLOBETelesis Bio Appoints William J. Kullback Chief Financial..
30/8/202306:02EDGAR2Form 8-K - Current report
11/8/202320:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:17EDGAR2Form 8-K - Current report
11/8/202306:05GLOBETelesis Bio Reports Second Quarter 2023 Financial Results
04/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
04/8/202307:00GLOBETelesis Bio to Report Second Quarter Financial Results on..
28/7/202307:28EDGAR2Form S-3 - Registration statement under Securities Act of..
08/7/202306:01EDGAR2Form 8-K - Current report
08/6/202323:05GLOBETelesis Bio to Present at Jefferies Healthcare Conference..
06/6/202317:00GLOBETelesis Bio to Present at Antibody Engineering and..
06/6/202307:30GLOBETelesis Bio Announces Closing of $28.0 Million Private..
01/6/202307:29GLOBETelesis Bio Secures Financing of $28.0 Million
23/5/202323:00GLOBETelesis Bio to Present at SynBioBeta 2023
23/5/202302:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
19/5/202300:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
15/5/202323:00GLOBETelesis Bio to Present at Protein Engineering Summit (PEGS..
12/5/202306:05GLOBETelesis Bio Reports First Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock